Lif CEO Sofia Wallström urges focus on timely access in pharma inquiry

TLV updates government on US pricing policy monitoring

Lif chair re-elected amid focus on alignment

Denmark consults on reimbursement status for cancer medicines

CHMP backs five new medicines in March 2026

Danish Medicines Council declines vamorolone for Duchenne

Sykehusinnkjøp switches procurement platform to Ivalua

Lif urges five priorities for Denmark’s next government

Danish Cancer Society warns MFN could slow access in Denmark

EFPIA report warns Europe is losing life sciences ground